05/21/2007
Federal Register Notice: FDA has determined the regulatory review period for AstraZeneca’s Iressa is 1,967 days for extendin...05/21/2007
Federal Register Notice: FDA has determined the regulatory review period for Guidant Corp.’s Galileo Intravascular Radiother...05/21/2007
Federal Register Notice: FDA is releasing “Modifications to the List of Recognized Standards, Recognition List Number: 017&r...05/14/2007
Federal Register Notice: FDA is seeking public comment on the collection of information contained in the guidance Information Prog...05/10/2007
Federal Register Notice: FDA is making available a draft guidance for industry entitled Protecting the Rights, Safety, and Welfare...05/10/2007
Federal Register Notice: FDA is amending the 4/16 notice of a meeting of the Vaccines and Related Biological Products Advisory Com...05/10/2007
Federal Register Notice: FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee will meet 6/27, fr...05/10/2007
Federal Register Notice: FDA is making available a guidance for industry entitled Computerized Systems Used in Clinical Investigat...